PL377238A1 - Nowy proces syntezy perindoprylu i jego farmaceutycznie dopuszczalnej soli - Google Patents

Nowy proces syntezy perindoprylu i jego farmaceutycznie dopuszczalnej soli

Info

Publication number
PL377238A1
PL377238A1 PL377238A PL37723804A PL377238A1 PL 377238 A1 PL377238 A1 PL 377238A1 PL 377238 A PL377238 A PL 377238A PL 37723804 A PL37723804 A PL 37723804A PL 377238 A1 PL377238 A1 PL 377238A1
Authority
PL
Poland
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salt
new process
Prior art date
Application number
PL377238A
Other languages
English (en)
Other versions
PL215131B1 (pl
Inventor
Thierry Dubuffet
Pascal Langlois
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL377238A1 publication Critical patent/PL377238A1/pl
Publication of PL215131B1 publication Critical patent/PL215131B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL377238A 2003-02-28 2004-02-27 Sposób wytwarzania perindoprilu i jego farmaceutycznie dopuszczalnych soli PL215131B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290485A EP1403275B1 (fr) 2003-02-28 2003-02-28 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
PL377238A1 true PL377238A1 (pl) 2006-01-23
PL215131B1 PL215131B1 (pl) 2013-10-31

Family

ID=31970533

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377238A PL215131B1 (pl) 2003-02-28 2004-02-27 Sposób wytwarzania perindoprilu i jego farmaceutycznie dopuszczalnych soli

Country Status (17)

Country Link
US (1) US7166633B2 (pl)
EP (1) EP1403275B1 (pl)
JP (1) JP4563372B2 (pl)
CN (1) CN1326871C (pl)
AR (1) AR043409A1 (pl)
AT (1) ATE307139T1 (pl)
AU (1) AU2004217599B2 (pl)
DE (1) DE60301930T2 (pl)
DK (1) DK1403275T3 (pl)
EA (1) EA009066B1 (pl)
ES (1) ES2250846T3 (pl)
MY (1) MY136989A (pl)
NZ (1) NZ541424A (pl)
PL (1) PL215131B1 (pl)
SI (1) SI1403275T1 (pl)
WO (1) WO2004078107A2 (pl)
ZA (1) ZA200505781B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1403275B1 (fr) * 2003-02-28 2005-10-19 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
ATE515496T1 (de) * 2004-12-28 2011-07-15 Dsm Ip Assets Bv Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ES2832323T3 (es) 2013-12-27 2021-06-10 Molten Corp Pelota
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
EP1472094B1 (en) * 2002-02-07 2011-09-14 Ricoh Company, Ltd. Pressure adjustment mechanism and inkjet printing apparatus
EP1403275B1 (fr) * 2003-02-28 2005-10-19 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Also Published As

Publication number Publication date
PL215131B1 (pl) 2013-10-31
AU2004217599B2 (en) 2009-07-30
ES2250846T3 (es) 2006-04-16
EA200501258A1 (ru) 2006-04-28
ZA200505781B (en) 2006-11-29
CN1753906A (zh) 2006-03-29
JP2006519177A (ja) 2006-08-24
HK1086281A1 (zh) 2006-09-15
AU2004217599A1 (en) 2004-09-16
SI1403275T1 (sl) 2006-02-28
CN1326871C (zh) 2007-07-18
DE60301930T2 (de) 2006-07-27
EP1403275A1 (fr) 2004-03-31
ATE307139T1 (de) 2005-11-15
EP1403275B1 (fr) 2005-10-19
WO2004078107A2 (fr) 2004-09-16
AR043409A1 (es) 2005-07-27
NZ541424A (en) 2008-03-28
WO2004078107A3 (fr) 2004-10-21
EA009066B1 (ru) 2007-10-26
US7166633B2 (en) 2007-01-23
JP4563372B2 (ja) 2010-10-13
US20060149081A1 (en) 2006-07-06
DE60301930D1 (de) 2006-03-02
MY136989A (en) 2008-12-31
DK1403275T3 (da) 2005-12-05

Similar Documents

Publication Publication Date Title
ZA200510324B (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
SI1420028T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1367061T1 (sl) Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
PL377238A1 (pl) Nowy proces syntezy perindoprylu i jego farmaceutycznie dopuszczalnej soli
SI1380590T1 (sl) Postopek za sintezo perindoprila in njenih farmacevtsko sprejemljivih soli
DE60300581D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
DE60301820D1 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
SI1420029T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1380591T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
PL379625A1 (pl) Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
PL379631A1 (pl) Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
SI1422236T1 (sl) Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
AU2003224327A8 (en) Process for the synthesis of peptides